Leap Therapeutics, Inc. (LPTX)

NASDAQ: LPTX · IEX Real-Time Price · USD
1.16
0.00 (0.00%)
At close: Aug 8, 2022 4:00 PM
1.19
+0.03 (2.76%)
After-hours: Aug 8, 2022 5:18 PM EDT
0.00%
Market Cap 102.45M
Revenue (ttm) 1.13M
Net Income (ttm) -41.83M
Shares Out 88.32M
EPS (ttm) -0.44
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 249,032
Open 1.16
Previous Close 1.16
Day's Range 1.13 - 1.21
52-Week Range 0.92 - 4.17
Beta 0.57
Analysts Buy
Price Target 4.49 (+287.1%)
Earnings Date Aug 11, 2022

About LPTX

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly kn... [Read more...]

Industry Biotechnology
Founded 2011
Employees 36
Stock Exchange NASDAQ
Ticker Symbol LPTX
Full Company Profile

Financial Performance

In 2021, LPTX's revenue was $1.50 million, a change of 0.00% compared to the previous year's $1.50 million. Losses were -$40.59 million, 47.5% more than in 2020.

Financial Statements

Analyst Forecast

According to 11 analysts, the average rating for LPTX stock is "Buy." The 12-month stock price forecast is 4.49, which is an increase of 287.07% from the latest price.

Price Target
$4.49
(287.07% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Leap Therapeutics Announces Initiation of New DKN-01 Clinical Trials in Gastric Cancer, Colorectal Cancer and Endomet...

Randomized Controlled First-Line Gastric Cancer Trial of DKN-01 plus tislelizumab and chemotherapy in collaboration with BeiGene Leap to host R&D Day today at 12:00 p.m. ET CAMBRIDGE, Mass.

Other symbols: BGNE

Ride on Rising P/E Investing With These 5 Top-Ranked Stocks

Want to try an out-of-the-box approach? Tap Oncolytics Biotech (ONCY), Pediatrix Medical Group Inc (MD), Boot Barn (BOOT), Canada Goose (GOOS) and Leap Therapeutics (LPTX).

Other symbols: BOOTGOOSMDONCY

Leap Therapeutics to Host Virtual R&D Day on July 12, 2022

CAMBRIDGE, Mass. , June 27, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it ...

Leap Therapeutics to Present Initial Data from the Investigator-Sponsored Study of DKN-01 Plus Docetaxel in Patients ...

CAMBRIDGE, Mass. , May 26, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that init...

Leap Therapeutics Reports First Quarter 2022 Financial Results

CAMBRIDGE, Mass. , May 13, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial r...

Check These 3 Penny Stocks Out For Your Watchlist Right in Late-April

Check these three penny stocks out for your watchlist right now The post Check These 3 Penny Stocks Out For Your Watchlist Right in Late-April  appeared first on Penny Stocks to Buy, Picks, News and Inf...

Other symbols: BAOSMDVL

Leap Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results

CAMBRIDGE, Mass., March 11, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial ...

Leap Therapeutics to Present at Raymond James 43rd Annual Institutional Investors Conference

CAMBRIDGE, Mass., March 2, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Doug...

Leap Therapeutics to Present at B. Riley Securities Oncology Investor Conference

CAMBRIDGE, Mass., Jan. 24, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Dougl...

Why Leap Therapeutics Stock Is Surging Today

Positive clinical trial results are giving investors a reason to cheer.

These 2 Nasdaq Stocks Are Poised to Make Big Moves Today

These clinical-stage biotech stocks are headed in opposite directions today.

Other symbols: CRDF

Leap Therapeutics Says DKN-01 Combo Regime Show Compelling Efficacy In Gastric Cancer Patients

Leap Therapeutics Inc (NASDAQ: LPTX) will present updated data from the DisTinGuish Phase 2a study of DKN-01, in combination with tislelizumab in gastric or gastric gastroesophageal junction cancer (G/G...

Leap Therapeutics to Present Positive New Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ASCO GI ...

CAMBRIDGE, Mass., Jan. 18, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused  on developing targeted and immuno-oncology therapeutics, today announced the Compa...

2 Risky Growth Stocks That Could Make You Filthy Rich

These two biotech stocks are set to report key clinical data later this year.

Other symbols: PIRS

7 Short Squeeze Penny Stocks To Buy For Under $5 Right Now

Short squeeze penny stocks to watch right now. The post 7 Short Squeeze Penny Stocks To Buy For Under $5 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols: CELZGMVDLIXTSEACTELL

Leap Therapeutics to Present at H.C. Wainwright BioConnect 2022 Conference

CAMBRIDGE, Mass., Jan. 5, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Dougl...

Leap Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 3, 2022 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Dougl...

Top Penny Stocks To Buy According To Analysts & Targets Up To 615%

Penny stocks with hight hopes from analysts. The post Top Penny Stocks To Buy According To Analysts & Targets Up To 615% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks....

Other symbols: ACRXKPLT

Best Penny Stocks To Buy Now For A Short Squeeze? 5 To Watch

Looking for short squeeze penny stocks? Give these 5 a look.

Other symbols: HCDIKALAKPLTVTNR

Hot Biotech Penny Stocks to Watch As New Variant Creates Volatility

Check these three biotech penny stocks out for your list this month The post Hot Biotech Penny Stocks to Watch As New Variant Creates Volatility appeared first on Penny Stocks to Buy, Picks, News and In...

Other symbols: DFFNIBIO

Leap Therapeutics to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference

CAMBRIDGE, Mass. , Nov. 15, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that memb...

Leap Therapeutics Reports Third Quarter 2021 Financial Results

CAMBRIDGE, Mass., Nov. 12, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial r...

Earnings Preview: Leap Therapeutics, Inc. (LPTX) Q3 Earnings Expected to Decline

Leap Therapeutics, Inc. (LPTX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Best Short Squeeze Penny Stocks To Buy? 4 To Watch Right Now

Are these the top penny stocks to watch for a short squeeze? The post Best Short Squeeze Penny Stocks To Buy?

Other symbols: BESTGOTURIDE

2 Penny Stocks That Could Soar Soon

These two tiny drugmakers might be hidden gems.

Other symbols: PIRS